Dr. Ryan Cole told RFK Jr., on “The Defender Podcast,” that viruses aren’t politically red or blue and the key to fighting the Delta variant is to test and treat early using a multi-drug approach.
When Dr. Ryan Cole decided to become a physician, he took an oath to protect his patients and to treat them to the best of his ability.
Cole, CEO of Cole Diagnostics and a board-certified dermatopathologist trained at the Mayo Clinic, said he has a motto when it comes to the coronavirus: Test and treat — and treat earlier with the Delta variant.
Cole told Children’s Health Defense Chairman Robert F. Kennedy, Jr., on the “RFK Jr. The Defender Podcast,” that while the Delta variant is spreading “like a wildfire right now,” data show it’s less deadly.
Cole, who reviews the lab tests of about 30,000 patients a year at his independent lab in Boise, Idaho, said he uses a multi-drug approach when treating patients for COVID.
Some of the drugs he’s found effective include ivermectin — an antiparasitic drug proven beneficial for treating SARS-CoV-2 — hydroxychloroquine, steroids, and the cholesterol drug fenofibrate and fluvoxamine for patients with neural symptoms.
Monoclonal antibodies are a good treatment, too, said Cole.
Treatments using monoclonal antibodies are “parked in infusion centers and emergency rooms around the country,” said Cole. “But there are crickets about this drug that decreases death and hospitalization by 50%.”
Cole told Kennedy his first COVID patient was…
<strong>Read full story</strong> [icon name=”arrow-right” prefix=”fas”] Mayo Clinic-Trained Pathologist Tells RFK, Jr.: Early Treatment Is Key to Fighting Delta Variant • Children’s Health Defense